JPS58222032A - 百日咳毒素のサブユニツト蛋白 - Google Patents

百日咳毒素のサブユニツト蛋白

Info

Publication number
JPS58222032A
JPS58222032A JP57103777A JP10377782A JPS58222032A JP S58222032 A JPS58222032 A JP S58222032A JP 57103777 A JP57103777 A JP 57103777A JP 10377782 A JP10377782 A JP 10377782A JP S58222032 A JPS58222032 A JP S58222032A
Authority
JP
Japan
Prior art keywords
activity
subunit protein
pertussal
polyacrylamide gel
gel electrophoresis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57103777A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0123447B2 (enExample
Inventor
Shoji Ono
小野　章二
Yoji Suzuki
洋二 鈴木
Atsushi Imaizumi
厚 今泉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP57103777A priority Critical patent/JPS58222032A/ja
Publication of JPS58222032A publication Critical patent/JPS58222032A/ja
Publication of JPH0123447B2 publication Critical patent/JPH0123447B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP57103777A 1982-06-18 1982-06-18 百日咳毒素のサブユニツト蛋白 Granted JPS58222032A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP57103777A JPS58222032A (ja) 1982-06-18 1982-06-18 百日咳毒素のサブユニツト蛋白

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57103777A JPS58222032A (ja) 1982-06-18 1982-06-18 百日咳毒素のサブユニツト蛋白

Publications (2)

Publication Number Publication Date
JPS58222032A true JPS58222032A (ja) 1983-12-23
JPH0123447B2 JPH0123447B2 (enExample) 1989-05-02

Family

ID=14362860

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57103777A Granted JPS58222032A (ja) 1982-06-18 1982-06-18 百日咳毒素のサブユニツト蛋白

Country Status (1)

Country Link
JP (1) JPS58222032A (enExample)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002754A1 (en) * 1986-10-20 1988-04-21 Trion Forskning- Och Utvecklings Aktiebolag New peptides and applications thereof
WO1988004665A1 (en) * 1986-12-22 1988-06-30 Trion Forskning- Och Utvecklings Aktiebolag A new pertussis toxin derived polypeptide and applications thereof
JPS6485926A (en) * 1987-06-24 1989-03-30 Teijin Ltd Mutant of bordetella pertussis
US4849358A (en) * 1987-04-24 1989-07-18 The Research Foundation For Microbial Diseases Of Osaka University Method for culturing bordetella pertussis, a pertussis toxoid and a pertussis vaccine
EP0747058A1 (en) 1989-05-08 1996-12-11 Evans Medical Limited Acellular vaccine

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002754A1 (en) * 1986-10-20 1988-04-21 Trion Forskning- Och Utvecklings Aktiebolag New peptides and applications thereof
WO1988004665A1 (en) * 1986-12-22 1988-06-30 Trion Forskning- Och Utvecklings Aktiebolag A new pertussis toxin derived polypeptide and applications thereof
US4849358A (en) * 1987-04-24 1989-07-18 The Research Foundation For Microbial Diseases Of Osaka University Method for culturing bordetella pertussis, a pertussis toxoid and a pertussis vaccine
JPS6485926A (en) * 1987-06-24 1989-03-30 Teijin Ltd Mutant of bordetella pertussis
EP0747058A1 (en) 1989-05-08 1996-12-11 Evans Medical Limited Acellular vaccine

Also Published As

Publication number Publication date
JPH0123447B2 (enExample) 1989-05-02

Similar Documents

Publication Publication Date Title
ES2198405T3 (es) Antigenos de superficie de tipo i asociados a staphylococcus epidermis.
Frasch et al. An outer membrane protein of Neisseria meningitidis group B responsible for serotype specificity
US5897867A (en) Efficacious vaccines against Bordetella pertussis comprising a combination of individually purified pertussis antigens
CA1231643A (en) Composition of intravenous immune globulin
JPH02797A (ja) ポリペプチドおよびその誘導体、ならびにそれを含有する医薬および診断組成物
HU181957B (en) Process for producing protein-type antygene compositions /preparates/ against caries
Gatto et al. Characterization of, and immune responses of mice to, the purified OmpA-equivalent outer membrane protein of Pasteurella multocida serotype A: 3 (Omp28)
JPS58500948A (ja) 「う」蝕症からの保護
US4567041A (en) Mutant strain of Listeria monocytogenes and its use in production of IgM antibodies and as an immunotherapeutic agent
JP2950970B2 (ja) 百日咳菌からの６９０００ダルトンの抗原性タンパク質の精製方法
JPH11511735A (ja) 非細胞性（Ａｃｅｌｌｕｌａｒ）百日咳ワクチン及びその調製方法
PT87065B (pt) Processo para a preparacao de uma vacina contra a pasteurelose
Irons et al. Substrate specificity and purification by affinity combination methods of the two Bordetella pertussis hemagglutinins
CA1192840A (en) Haemophilus influenzae type b and pertussis outer membrane component combined vaccine
JPS58222032A (ja) 百日咳毒素のサブユニツト蛋白
PT90310B (pt) Processo para a obtencao de preparacoes de adenilato-ciclase
JPH0723398B2 (ja) 初乳由来ポリペプチド因子
NZ566871A (en) Protein A Production and Purification without Using Animal Derived Components involving staphylococcus aureus
JPH03151400A (ja) 化学修飾されたアレルゲン類およびそれらの調製方法
GB2060647A (en) Antigens ex. Streptococcus mutans
CA1128860A (en) Peptide complexes of dna-containing organisms
IE41909B1 (en) Derivatives of diphtherial toxin, process for preparin them and agents containing them
WO1981001101A1 (en) Improvements in or relating to vaccines
CN107245476B (zh) 单克隆抗体6c9g4及其在制备治疗内毒素血症的药物中的应用
Loyer et al. Comparative study of hemolytic substances produced by coagulase-negative Staphylococcus strains